Innoviva, Inc. (INVA)
USD 18.37
(-0.7%)
USD 18.37
(-0.7%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 449.07 Million USD | -29.6% |
| 2022 | 637.88 Million USD | 61.63% |
| 2021 | 394.65 Million USD | 2.37% |
| 2020 | 385.51 Million USD | 2.23% |
| 2019 | 377.12 Million USD | -1.5% |
| 2018 | 382.85 Million USD | -36.12% |
| 2017 | 599.36 Million USD | -16.3% |
| 2016 | 716.09 Million USD | -4.3% |
| 2015 | 748.27 Million USD | 3.12% |
| 2014 | 725.63 Million USD | 152.4% |
| 2013 | 287.5 Million USD | 66.67% |
| 2012 | 172.5 Million USD | -0.04% |
| 2011 | 172.56 Million USD | -0.12% |
| 2010 | 172.77 Million USD | -0.11% |
| 2009 | 172.95 Million USD | 0.01% |
| 2008 | 172.93 Million USD | 32164.18% |
| 2007 | 536 Thousand USD | -14.24% |
| 2006 | 625 Thousand USD | -66.67% |
| 2005 | 1.87 Million USD | -57.39% |
| 2004 | 4.4 Million USD | -44.09% |
| 2003 | 7.87 Million USD | -78.17% |
| 2002 | 36.05 Million USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 450.71 Million USD | 0.31% |
| 2024 Q1 | 449.33 Million USD | 0.06% |
| 2023 Q1 | 444.69 Million USD | -30.29% |
| 2023 FY | 449.07 Million USD | -29.6% |
| 2023 Q2 | 448.28 Million USD | 0.81% |
| 2023 Q3 | 448.88 Million USD | 0.13% |
| 2023 Q4 | 449.07 Million USD | 0.04% |
| 2022 Q3 | 543.68 Million USD | 0.12% |
| 2022 Q2 | 543.02 Million USD | -14.98% |
| 2022 Q4 | 637.88 Million USD | 17.33% |
| 2022 Q1 | 638.68 Million USD | 61.83% |
| 2022 FY | 637.88 Million USD | 61.63% |
| 2021 FY | 394.65 Million USD | 2.37% |
| 2021 Q1 | 387.72 Million USD | 0.57% |
| 2021 Q2 | 389.98 Million USD | 0.58% |
| 2021 Q3 | 392.29 Million USD | 0.59% |
| 2021 Q4 | 394.65 Million USD | 0.6% |
| 2020 Q4 | 385.51 Million USD | 0.57% |
| 2020 Q3 | 383.35 Million USD | 0.56% |
| 2020 Q2 | 381.23 Million USD | 0.55% |
| 2020 Q1 | 379.15 Million USD | 0.54% |
| 2020 FY | 385.51 Million USD | 2.23% |
| 2019 Q1 | 386.29 Million USD | 0.9% |
| 2019 FY | 377.12 Million USD | -1.5% |
| 2019 Q2 | 386.67 Million USD | 0.1% |
| 2019 Q3 | 388.64 Million USD | 0.51% |
| 2019 Q4 | 377.12 Million USD | -2.97% |
| 2018 FY | 382.85 Million USD | -36.12% |
| 2018 Q4 | 382.85 Million USD | 0.49% |
| 2018 Q1 | 484.59 Million USD | -19.15% |
| 2018 Q2 | 486.52 Million USD | 0.4% |
| 2018 Q3 | 381 Million USD | -21.69% |
| 2017 Q3 | 603.44 Million USD | -7.71% |
| 2017 Q1 | 709.02 Million USD | -0.99% |
| 2017 FY | 599.36 Million USD | -16.3% |
| 2017 Q4 | 599.36 Million USD | -0.68% |
| 2017 Q2 | 653.89 Million USD | -7.78% |
| 2016 Q2 | 725.55 Million USD | -1.22% |
| 2016 FY | 716.09 Million USD | -4.3% |
| 2016 Q4 | 716.09 Million USD | -0.96% |
| 2016 Q3 | 723 Million USD | -0.35% |
| 2016 Q1 | 734.51 Million USD | -1.84% |
| 2015 FY | 748.27 Million USD | 3.12% |
| 2015 Q4 | 748.27 Million USD | 0.56% |
| 2015 Q3 | 744.08 Million USD | 0.76% |
| 2015 Q2 | 738.47 Million USD | 0.88% |
| 2015 Q1 | 732.06 Million USD | 0.89% |
| 2014 Q3 | 705.1 Million USD | -4.39% |
| 2014 FY | 725.63 Million USD | 152.4% |
| 2014 Q4 | 725.63 Million USD | 2.91% |
| 2014 Q1 | 287.5 Million USD | 0.0% |
| 2014 Q2 | 737.5 Million USD | 156.52% |
| 2013 Q4 | 287.5 Million USD | 0.0% |
| 2013 Q2 | 459.96 Million USD | -0.01% |
| 2013 Q1 | 460 Million USD | 166.67% |
| 2013 Q3 | 287.5 Million USD | -37.49% |
| 2013 FY | 287.5 Million USD | 66.67% |
| 2012 FY | 172.5 Million USD | -0.04% |
| 2012 Q1 | 172.5 Million USD | -0.04% |
| 2012 Q4 | 172.5 Million USD | 0.0% |
| 2012 Q2 | 172.5 Million USD | 0.0% |
| 2012 Q3 | 172.5 Million USD | 0.0% |
| 2011 Q3 | 172.6 Million USD | -0.03% |
| 2011 FY | 172.56 Million USD | -0.12% |
| 2011 Q1 | 172.71 Million USD | -0.04% |
| 2011 Q2 | 172.66 Million USD | -0.03% |
| 2011 Q4 | 172.56 Million USD | -0.02% |
| 2010 Q4 | 172.77 Million USD | -0.02% |
| 2010 FY | 172.77 Million USD | -0.11% |
| 2010 Q3 | 172.81 Million USD | -0.03% |
| 2010 Q2 | 172.87 Million USD | -0.02% |
| 2010 Q1 | 172.9 Million USD | -0.03% |
| 2009 Q4 | 172.95 Million USD | -0.02% |
| 2009 FY | 172.95 Million USD | 0.01% |
| 2009 Q1 | 172.9 Million USD | -0.02% |
| 2009 Q2 | 173.03 Million USD | 0.07% |
| 2009 Q3 | 172.99 Million USD | -0.02% |
| 2008 Q3 | 172.96 Million USD | -0.02% |
| 2008 FY | 172.93 Million USD | 32164.18% |
| 2008 Q1 | 173.01 Million USD | 32178.54% |
| 2008 Q4 | 172.93 Million USD | -0.02% |
| 2008 Q2 | 172.98 Million USD | -0.01% |
| 2007 Q1 | 604 Thousand USD | -3.36% |
| 2007 FY | 536 Thousand USD | -14.24% |
| 2007 Q4 | 536 Thousand USD | -4.29% |
| 2007 Q3 | 560 Thousand USD | -3.78% |
| 2007 Q2 | 582 Thousand USD | -3.64% |
| 2006 FY | 625 Thousand USD | -66.67% |
| 2006 Q4 | 625 Thousand USD | -43.64% |
| 2006 Q3 | 1.1 Million USD | -12.12% |
| 2006 Q2 | 1.26 Million USD | -21.57% |
| 2006 Q1 | 1.6 Million USD | -14.19% |
| 2005 Q4 | 1.87 Million USD | -13.83% |
| 2005 Q2 | 2.49 Million USD | -22.11% |
| 2005 FY | 1.87 Million USD | -57.39% |
| 2005 Q3 | 2.17 Million USD | -12.75% |
| 2005 Q1 | 3.2 Million USD | -27.23% |
| 2004 Q4 | 4.4 Million USD | -18.82% |
| 2004 Q2 | 6.19 Million USD | 0.0% |
| 2004 Q3 | 5.42 Million USD | -12.5% |
| 2004 FY | 4.4 Million USD | -44.09% |
| 2003 FY | 7.87 Million USD | -78.17% |
| 2002 FY | 36.05 Million USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AnaptysBio, Inc. | 17.81 Million USD | -2420.916% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -342.946% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -331.05% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 83.26% |
| Fortress Biotech, Inc. | 88.59 Million USD | -406.904% |
| Fortress Biotech, Inc. | 88.59 Million USD | -406.904% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -55451.075% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -813959.639% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1386.552% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -3009.083% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -7184.282% |
| MiMedx Group, Inc. | 48.09 Million USD | -833.649% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1227.449% |
| IO Biotech, Inc. | 2.49 Million USD | -17906.255% |
| NextCure, Inc. | 6.6 Million USD | -6699.031% |
| Opthea Limited | 200.62 Million USD | -123.834% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1163.037% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1782.791% |
| Precigen, Inc. | 7.09 Million USD | -6227.688% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -27366.422% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -2005.274% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -1489.143% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1078.553% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -154944.658% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -7133.827% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1092.258% |
| Acelyrin, Inc. | 1.19 Million USD | -37511.055% |
| TG Therapeutics, Inc. | 110.79 Million USD | -305.322% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1298.207% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -95.94% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -6746.714% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -8132.374% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -7225.873% |
| AlloVir, Inc. | 27.42 Million USD | -1537.231% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -2014.393% |
| Onconetix, Inc. | 9.88 Million USD | -4442.65% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -223.007% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 92.253% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -623.441% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -49466.887% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -444529.703% |
| PureTech Health plc | 25.51 Million USD | -1660.254% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -641.306% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -283.194% |
| Dyadic International, Inc. | 136.92 Thousand USD | -327862.667% |
| Jaguar Health, Inc. | 35.86 Million USD | -1152.303% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -191427.31% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -21082.83% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 12.23 Million USD | -3571.922% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -233.876% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1657.223% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -6293.451% |
| Agenus Inc. | 350.24 Million USD | -28.217% |
| Royalty Pharma plc | 6.13 Billion USD | 92.68% |
| Bicycle Therapeutics plc | 44.95 Million USD | -898.923% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -2050.311% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1390.115% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -333.739% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -15536.351% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -46292.149% |
| Vaxxinity, Inc. | 15.16 Million USD | -2860.68% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -532.715% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -141118.868% |
| Clearside Biomedical, Inc. | 43 Million USD | -944.339% |
| CRISPR Therapeutics AG | 238.63 Million USD | -88.188% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -558952.883% |
| Incyte Corporation | 38.28 Million USD | -1072.92% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1729.826% |
| ContextLogic Inc. | 6 Million USD | -7384.6% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -113.702% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -886.763% |
| Aptorum Group Limited | 3.36 Million USD | -13255.829% |
| Ardelyx, Inc. | 55.98 Million USD | -702.179% |
| Pharming Group N.V. | 171.54 Million USD | -161.783% |
| Chimerix, Inc. | 2.14 Million USD | -20845.709% |
| ChromaDex Corporation | 3.27 Million USD | -13603.875% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1473.442% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1533.895% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -99568.199% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -558.18% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -27067.332% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -5764.604% |
| Structure Therapeutics Inc. | 5.45 Million USD | -8135.392% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -3360.82% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -284125.316% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -79382.478% |
| AbCellera Biologics Inc. | 77.38 Million USD | -480.352% |
| Alkermes plc | 290.73 Million USD | -54.465% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -26519.798% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -4458.222% |
| Geron Corporation | 85.89 Million USD | -422.795% |
| Summit Therapeutics Inc. | 106.09 Million USD | -323.261% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -6470.241% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -2568.307% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -72098.366% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -94442.316% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -306.927% |
| Vaxcyte, Inc. | 29.22 Million USD | -1436.668% |
| ADMA Biologics, Inc. | 141.41 Million USD | -217.552% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -289.921% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -209748.598% |
| Novavax, Inc. | 280.63 Million USD | -60.021% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -2209.468% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -149236.579% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -25813.214% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -12525.134% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1336.216% |
| GT Biopharma, Inc. | 58 Thousand USD | -774168.966% |
| ImmuCell Corporation | 11.96 Million USD | -3651.898% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 118.92 Million USD | -277.619% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1693.291% |
| Aptose Biosciences Inc. | 1 Million USD | -44371.512% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -5187931.423% |
| Soligenix, Inc. | 3.49 Million USD | -12750.713% |
| Century Therapeutics, Inc. | 48.17 Million USD | -832.254% |
| Kura Oncology, Inc. | 17.2 Million USD | -2510.907% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -385.839% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -20787.256% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -3113.654% |
| Autolus Therapeutics plc | 52.96 Million USD | -747.841% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -8111.3% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -973.24% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -95.734% |
| GRI Bio, Inc. | 14 Thousand USD | -3207585.714% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -3514.585% |
| IGM Biosciences, Inc. | 40.5 Million USD | -1008.665% |
| INmune Bio, Inc. | 10.43 Million USD | -4202.731% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -150.003% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -7502.362% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -549699.216% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -54212.059% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -767.361% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -670.536% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -675.981% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 6.606% |
| Verastem, Inc. | 41.55 Million USD | -980.627% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -8216.222% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -3848.962% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -4476.338% |
| Histogen Inc. | 4.62 Million USD | -9616.054% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -13190.204% |
| Organovo Holdings, Inc. | 1.39 Million USD | -32114.921% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -876.216% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -8546.053% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -2103300.468% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -430.898% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -214748.34% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1386.219% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -276566.03% |
| Apollomics, Inc. | 4.66 Million USD | -9534.756% |
| Amarin Corporation plc | 8.73 Million USD | -5039.934% |
| Turnstone Biologics Corp. | 3.21 Million USD | -13872.495% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -430.359% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -181712.146% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -360.086% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -136.425% |
| Better Therapeutics, Inc. | 14.88 Million USD | -2917.984% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1366.897% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -304.836% |
| NLS Pharmaceutics AG | 1.63 Million USD | -27387.504% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -328.61% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -16019.024% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -918819.583% |
| Avid Bioservices, Inc. | 207.83 Million USD | -116.074% |
| Insmed Incorporated | 1.2 Billion USD | 62.701% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -6591.641% |
| OmniAb, Inc. | 25.56 Million USD | -1656.88% |
| Alector, Inc. | 38.91 Million USD | -1053.903% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -109.911% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -2864.002% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 6.136% |
| Aura Biosciences, Inc. | 19.55 Million USD | -2196.242% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -610.935% |
| Immunic, Inc. | 1.33 Million USD | -33563.868% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1315.215% |
| Veracyte, Inc. | 12.63 Million USD | -3455.629% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 30.361% |
| FibroGen, Inc. | 170.45 Million USD | -163.457% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4845.226% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -220131.375% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1213618.919% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -10498.914% |
| Galecto, Inc. | 249 Thousand USD | -180251.807% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -26855.342% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 73.237% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -6037.433% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -8220.845% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -16019.024% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1570.607% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -896.33% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -31547.357% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -892.74% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -940.274% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -831.133% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 47.087% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -43610.033% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -3999.279% |
| NexImmune, Inc. | 68.8 Thousand USD | -652541.37% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -3163743.878% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 83.385% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -114459.62% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -6402.693% |
| Ainos, Inc. | 5.96 Million USD | -7430.339% |
| Pluri Inc. | 29.61 Million USD | -1416.534% |
| Prothena Corporation plc | 11.83 Million USD | -3694.474% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1679.576% |
| Celularity Inc. | 65.41 Million USD | -586.482% |
| Rallybio Corporation | 392 Thousand USD | -114460.204% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2955.978% |
| MeiraGTx Holdings plc | 89.26 Million USD | -403.087% |
| Omeros Corporation | 338.28 Million USD | -32.752% |
| Humacyte, Inc. | 58.1 Million USD | -672.857% |
| Immunocore Holdings plc | 84.03 Million USD | -434.411% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -24135.078% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -9108.038% |
| Blueprint Medicines Corporation | 774.12 Million USD | 41.989% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -8849.303% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -626.449% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -331.406% |
| Pulmatrix, Inc. | 8.75 Million USD | -5028.78% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -6392.352% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -3142.426% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -289.329% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1323.469% |
| Cytokinetics, Incorporated | 755.77 Million USD | 40.58% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -3255.32% |
| Nutriband Inc. | 241.28 Thousand USD | -186018.491% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -8114.304% |
| Vor Biopharma Inc. | 35.66 Million USD | -1159.327% |
| Roivant Sciences Ltd. | 499.74 Million USD | 10.14% |
| Evogene Ltd. | 1.13 Million USD | -39361.863% |
| ProKidney Corp. | 4.41 Million USD | -10076.207% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -36529.364% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 74.189% |
| CorMedix Inc. | 667.63 Thousand USD | -67164.002% |
| BioLineRx Ltd. | 11.59 Million USD | -3774.351% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1053.844% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -525.393% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2625.637% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -18222.184% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -66429.778% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -881.094% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -690786.154% |
| MediciNova, Inc. | 215.92 Thousand USD | -207876.807% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -17899.038% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -35511.898% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -140.957% |
| Biomea Fusion, Inc. | 10.29 Million USD | -4261.655% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -8.204% |
| Mereo BioPharma Group plc | 5.95 Million USD | -7444.96% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -12409.081% |
| Absci Corporation | 15.95 Million USD | -2714.288% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4802.041% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2960.977% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1538.067% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -3563.534% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -3490.884% |
| Allakos Inc. | 41.46 Million USD | -983.024% |
| Imunon, Inc. | 1.62 Million USD | -27540.311% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -4050.042% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -297301.325% |
| BioAtla, Inc. | 2.46 Million USD | -18155.122% |
| NLS Pharmaceutics AG | 1.63 Million USD | -27387.504% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -397312.389% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -372.11% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -7997.295% |
| XOMA Corporation | 124.45 Million USD | -260.849% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -2271.922% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -940.322% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2874.998% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -3931.927% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1624.364% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -2033.58% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -128575.072% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -137445.369% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -27421.549% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 70.047% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -273781.94% |
| UroGen Pharma Ltd. | 100.21 Million USD | -348.117% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -145.734% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -129562.588% |
| Orgenesis Inc. | 22.62 Million USD | -1885.217% |
| Entera Bio Ltd. | 390 Thousand USD | -115047.692% |
| GH Research PLC | 343 Thousand USD | -130825.948% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -147138.033% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -46053.751% |
| Xencor, Inc. | 83.43 Million USD | -438.241% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -259973.086% |
| Replimune Group, Inc. | 75.86 Million USD | -491.91% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -36582.443% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -4675.372% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -273781.94% |
| Portage Biotech Inc. | 47 Thousand USD | -955380.851% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -35511.898% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -18479.892% |
| OncoCyte Corporation | 2.86 Million USD | -15552.701% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -34465.153% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -298182.344% |
| Purple Biotech Ltd. | 351 Thousand USD | -127841.88% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -14115.764% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1015.19% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -777.221% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -316150.704% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -8484.898% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1579.542% |
| Curis, Inc. | 2.79 Million USD | -15972.87% |
| Daré Bioscience, Inc. | 5.31 Million USD | -8344.223% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -20919.739% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -2584.095% |
| BeiGene, Ltd. | 930.18 Million USD | 51.722% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -2789.342% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -410.639% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -39258.107% |
| Erasca, Inc. | 55.85 Million USD | -703.946% |
| bluebird bio, Inc. | 330.32 Million USD | -35.949% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 60.395% |
| DBV Technologies S.A. | 14.38 Million USD | -3022.704% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -17848.681% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -9570.026% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -10.942% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -875.425% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -9643.458% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -17566.247% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -2281.987% |
| MacroGenics, Inc. | 33.97 Million USD | -1221.939% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -2046.224% |
| Prime Medicine, Inc. | 13.63 Million USD | -3194.037% |
| Aditxt, Inc. | 18.21 Million USD | -2365.014% |
| Adagene Inc. | 22.3 Million USD | -1913.173% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2834.562% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 26.498% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -2112.96% |
| SciSparc Ltd. | 76 Thousand USD | -590789.474% |
| Vericel Corporation | 88.14 Million USD | -409.486% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -447.541% |
| Generation Bio Co. | 97.89 Million USD | -358.737% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -136397.264% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1675.144% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -118.087% |
| Invivyd, Inc. | 2.16 Million USD | -20642.54% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -739.928% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -12744236.257% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -8001.678% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -712719.048% |
| 2seventy bio, Inc. | 256.67 Million USD | -74.96% |
| Clene Inc. | 32.16 Million USD | -1296.337% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -7901.847% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -20359.043% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -786.241% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -93215.463% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -132.451% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -1390.659% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -2511.362% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -260.588% |
| Evaxion Biotech A/S | 10.86 Million USD | -4031.456% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -438.531% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -499.511% |
| Trevena, Inc. | 35.23 Million USD | -1174.589% |
| Surrozen, Inc. | 3.37 Million USD | -13190.204% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -6813.116% |
| Cingulate Inc. | 3.13 Million USD | -14224.141% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1095207.317% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1563.861% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -89553.286% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -74373.632% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -685.029% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -96475.484% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1488.413% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -2121.059% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -28779.486% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -35540.952% |
| Statera Biopharma, Inc. | 16.26 Million USD | -2661.652% |
| ImmunityBio, Inc. | 883.67 Million USD | 49.181% |
| Korro Bio, Inc. | 33.2 Million USD | -1252.353% |
| Kineta, Inc. | 1.31 Million USD | -33998.405% |
| BioVie Inc. | 6.11 Million USD | -7248.112% |
| Codexis, Inc. | 22.36 Million USD | -1908.031% |
| Celularity Inc. | 65.41 Million USD | -586.482% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -768.149% |
| Celcuity Inc. | 37.44 Million USD | -1099.254% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -200112.216% |
| Cibus, Inc. | 24.62 Million USD | -1723.955% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -117152.219% |
| IN8bio, Inc. | 4.89 Million USD | -9077.928% |
| Kodiak Sciences Inc. | 181.63 Million USD | -147.245% |
| Annexon, Inc. | 31.35 Million USD | -1332.231% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -498.481% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -19074.893% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -11405.919% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 69.105% |
| Eyenovia, Inc. | 16.1 Million USD | -2687.948% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -302.795% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -45491.472% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -3819.665% |
| Arcellx, Inc. | 97.62 Million USD | -360.001% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -20796.975% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1593.795% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -14376.983% |
| Moolec Science SA | 2.64 Million USD | -16876.444% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1476.424% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -7013.512% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -18595.92% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -389540.273% |
| Humacyte, Inc. | 58.1 Million USD | -672.857% |
| 89bio, Inc. | 27.1 Million USD | -1556.618% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -3280.069% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -17727.551% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -33463.229% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -323.401% |
| Notable Labs, Ltd. | 2.04 Million USD | -21816.837% |
| Liquidia Corporation | 3.5 Million USD | -12719.754% |
| Mustang Bio, Inc. | 2.49 Million USD | -17877.422% |
| Immunovant, Inc. | 138 Thousand USD | -325317.391% |
| Quantum-Si incorporated | 15.3 Million USD | -2834.562% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -5049.364% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -112169.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -736.144% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -549699.216% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -4018.83% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -213248.916% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -221119.704% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -2073.544% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -111333.251% |
| PepGen Inc. | 20.1 Million USD | -2133.764% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -78136.237% |
| United Therapeutics Corporation | 700 Million USD | 35.846% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -1609.789% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -9962.293% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -50585.779% |
| XOMA Corporation | 124.45 Million USD | -260.849% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -163796.35% |
| Bionomics Limited | 239.61 Million USD | -87.413% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -21978.477% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3282.615% |
| uniQure N.V. | 138.4 Million USD | -224.456% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -425.709% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -43415.116% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -45491.472% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4845.226% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -25605.552% |
| Altimmune, Inc. | 671 Thousand USD | -66826.379% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -0.903% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3282.615% |
| Compugen Ltd. | 1.35 Million USD | -33140.266% |
| Peak Bio, Inc. | 10.72 Million USD | -4088.436% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -950.077% |
| Benitec Biopharma Inc. | 284 Thousand USD | -158025.352% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -431.105% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -2154.284% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -3712.514% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -391.019% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -2154.284% |
| Instil Bio, Inc. | 86.05 Million USD | -421.854% |
| argenx SE | 20 Million USD | -2145.38% |
| Immunome, Inc. | 1.65 Million USD | -27116.727% |
| Verona Pharma plc | 51.32 Million USD | -774.897% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -4492.718% |
| Shattuck Labs, Inc. | 4.2 Million USD | -10587.197% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -123954.144% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -10640.875% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -76665.128% |
| Moolec Science SA | 2.64 Million USD | -16876.444% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 3.05 Million USD | -14623.803% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -171303.053% |
| NeurAxis, Inc. | 224.26 Thousand USD | -200147.927% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -3056.283% |
| Lumos Pharma, Inc. | 6.58 Million USD | -6719.681% |
| Achilles Therapeutics plc | 4.61 Million USD | -9630.791% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -4492.718% |
| 180 Life Sciences Corp. | 1.32 Million USD | -33919.131% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -2529.232% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -28779.486% |
| Nutriband Inc. | 241.28 Thousand USD | -186018.491% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -4297.102% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -54267.554% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -20.163% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1391.996% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -12044.193% |
| Palisade Bio, Inc. | 369 Thousand USD | -121600.813% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -108111.084% |
| Beam Therapeutics Inc. | 173.17 Million USD | -159.322% |
| Neurogene Inc. | 16.25 Million USD | -2662.695% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -45.737% |
| AEON Biopharma, Inc. | 278 Thousand USD | -161438.129% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -133952.537% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -420025.174% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -491.964% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -634.901% |
| Athira Pharma, Inc. | 1.58 Million USD | -28232.871% |
| Vaccinex, Inc. | 247 Thousand USD | -181712.146% |
| HCW Biologics Inc. | 6.45 Million USD | -6860.501% |
| XOMA Corporation | 124.45 Million USD | -260.849% |
| Nektar Therapeutics | 230.4 Million USD | -94.911% |
| Arvinas, Inc. | 3.4 Million USD | -13108.118% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -27421.549% |
| Merus N.V. | 12.16 Million USD | -3592.452% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -249.671% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -3150.876% |
| Rezolute, Inc. | 2.22 Million USD | -20056.014% |
| Clene Inc. | 32.16 Million USD | -1296.337% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -256437.163% |
| BeyondSpring Inc. | 3.99 Million USD | -11140.951% |
| Synlogic, Inc. | 17.27 Million USD | -2499.572% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -34444.308% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1282974.286% |
| Peak Bio, Inc. | 10.72 Million USD | -4088.436% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -764.888% |
| Krystal Biotech, Inc. | 8.09 Million USD | -5448.259% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -153.692% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -6263.554% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -328667.003% |
| MannKind Corporation | 382.37 Million USD | -17.443% |
| Ikena Oncology, Inc. | 10.73 Million USD | -4082.12% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -109698.533% |
| Gossamer Bio, Inc. | 212.46 Million USD | -111.366% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -257989.655% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4802.041% |
| Legend Biotech Corporation | 328.67 Million USD | -36.633% |
| Mural Oncology plc | 15 Million USD | -2892.045% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -846.898% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -21274.393% |
| Champions Oncology, Inc. | 7.43 Million USD | -5944.092% |
| REGENXBIO Inc. | 89.29 Million USD | -402.941% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -52442.129% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -81109.877% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -8194.717% |
| Vaxart, Inc. | 26.51 Million USD | -1593.732% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2768.146% |
| Cellectis S.A. | 92.85 Million USD | -383.642% |
| Longeveron Inc. | 2.04 Million USD | -21902.744% |
| Repare Therapeutics Inc. | 3.41 Million USD | -13069.384% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 67.85% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -863.848% |
| Revolution Medicines, Inc. | 87.94 Million USD | -410.639% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -259481.503% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -11260.385% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -141564.353% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -256514.857% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 44.449% |
| Denali Therapeutics Inc. | 52.24 Million USD | -759.624% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -3017.401% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -32583.843% |
| Cingulate Inc. | 3.13 Million USD | -14224.141% |
| Passage Bio, Inc. | 26.29 Million USD | -1607.903% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -6637.824% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -109967.647% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -50132.215% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -2084.116% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -35540.952% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -18221.25% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -14279.635% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -55273.12% |
| OmniAb, Inc. | 25.56 Million USD | -1656.88% |
| Anew Medical, Inc. | 1.6 Million USD | -27879.813% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1418.027% |
| Lipocine Inc. | 17.16 Thousand USD | -2615978.294% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -3758.704% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1196.858% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -7502.362% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -685.469% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -221119.704% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -8594.598% |
| Ocugen, Inc. | 6.94 Million USD | -6369.903% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -3078.399% |
| Q32 Bio Inc. | 1.31 Million USD | -33972.534% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -66726.786% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1278.379% |
| Equillium, Inc. | 824 Thousand USD | -54399.515% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -4846.316% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -149190.905% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -194.865% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -778.165% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -57841.702% |
| Dominari Holdings Inc. | 3.02 Million USD | -14730.779% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -475178.081% |
| vTv Therapeutics Inc. | 529 Thousand USD | -84791.493% |
| Bio-Techne Corporation | 419.53 Million USD | -7.041% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -523.751% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -132.001% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -2559.143% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1872.92% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -7312.942% |
| Nkarta, Inc. | 88.33 Million USD | -408.355% |
| BioCardia, Inc. | 1.31 Million USD | -34050.266% |
| Iterum Therapeutics plc | 19.5 Million USD | -2201.891% |